Skip to content

Enumeral Biomedical Holdings, Inc.

CIK 0001561551

← back to feed
Revenue (TTM)
$1.57M
+808.0% YoY Q3 Nov 2017
Net Income (TTM)
−$6.98M
−460.4% YoY Q3 Nov 2017
EPS Diluted (TTM)
−$0.06
−450.0% YoY Q3 Nov 2017
Gross Margin
—
Q3 Nov 2017
Operating Margin
-408.2%
Q3 Nov 2017
Net Margin
-443.6%
Q3 Nov 2017
Free Cash Flow (TTM)
−$5.43M
Q3 Nov 2017
Cash
$208.62K
Q3 Nov 2017
Total Debt
$43.51K
Q3 Nov 2017
Shares Outstanding
128.41M sh
Q3 Nov 2017

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings